KOMBINATIONSTHERAPIE

European patent · EP2726095 · In force

Register entry

Publication number
EP2726095
Application number
EP12807960
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 2, 2012
Published
May 7, 2014
Granted
Jun 6, 2018
Protection ends at the latest
Jul 1, 2032
Next annual fee due
Jul 31, 2027
IPC classes
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
Priority
AU 2011902623 01.07.2011
PCT application
PCT/AU2012/000795 02.07.2012
PCT publication
WO2013/003895 10.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Jun 6, 2018

    Granted

    Published in Swissreg on 06.06.2018

Parties

Holder

Biosceptre (Aust) Pty Ltd

11 Julius Avenue, North Ryde, NSW 2113, AU

Inventor

BARDEN, Julian Alexander

North Ryde, New South Wales 2113, AU

GIDLEY-BAIRD, Angus

North Ryde, New South Wales 2113, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.